1
|
Tanzi RE, Petrukhin K, Chernov I,
Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L,
Brzustowicz LM, et al: The Wilson disease gene is a copper
transporting ATPase with homology to the Menkes disease gene. Nat
Genet. 5:344–350. 1993. View Article : Google Scholar : PubMed/NCBI
|
2
|
La Fontaine S and Mercer JFB: Trafficking
of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis.
Arch Biochem Biophys. 463:149–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
La Fontaine S, Ackland ML and Mercer JF:
Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B:
Emerging roles. Int J Biochem Cell Biol. 42:206–209. 2010.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Rosencrantz R and Schilsky M: Wilson
disease: Pathogenesis and clinical considerations in diagnosis and
treatment. Semin Liver Dis. 31:245–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Wu F, Wang J, Pu C, Qiao L and Jiang C:
Wilson's disease: a comprehensive review of the molecular
mechanisms. Int J Mol Sci. 16:6419–6431. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Loudianos G, Lepori MB, Mameli E, Dessì V
and Zappu A: Wilson's disease. Pril (Makedon Akad Nauk Umet Odd Med
Nauki). 35:93–98. 2014.PubMed/NCBI
|
7
|
Kozic D, Svetel M, Petrovic B, Dragasevic
N, Semnic R and Kostic VS: MR imaging of the brain in patients with
hepatic form of Wilson's disease. Eur J Neurol. 10:587–592. 2003.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Mittal S, Wu Z, Neelavalli J and Haacke
EM: Susceptibility-weighted imaging: Technical aspects and clinical
applications, part 2. AJNR Am J Neuroradiol. 30:232–252. 2009.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Haacke EM, Cheng NY, House MJ, Liu Q,
Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W and Obenaus A:
Imaging iron stores in the brain using magnetic resonance imaging.
Magn Reson Imaging. 23:1–25. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Haacke EM, Xu Y, Cheng YC and Reichenbach
JR: Susceptibility weighted imaging (SWI). Magn Reson Med.
52:612–618. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Barnes SR and Haacke EM:
Susceptibility-weighted imaging: clinical angiographic
applications. Magn Reson Imaging Clin N Am. 17:47–61. 2009.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Sehgal V, Delproposto Z, Haacke EM, Tong
KA, Wycliffe N, Kido DK, Xu Y, Neelavalli J, Haddar D and
Reichenbach JR: Clinical applications of neuroimaging ith
susceptibility-weighted imaging. J Magn Reson Imaging. 22:439–450.
2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang J, Zhang Y, Wang J, Cai P, Luo C,
Qian Z, Dai Y and Feng H: Characterizing iron deposition in
Parkinson's disease using susceptibility-weighted imaging: An in
vivo MR study. Brain Res. 1330:124–130. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wallis LI, Paley MN, Graham JM, Grünewald
RA, Wignall EL, Joy HM and Griffiths PD: MRI assessment of basal
ganglia iron deposition in Parkinson's disease. J Magn Reson
Imaging. 28:1061–1067. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Haacke EM, Ayaz M, Khan A, Manova ES,
Krishnamurthy B, Gollapalli L, Ciulla C, Kim I, Petersen F and
Kirsch W: Establishing a baseline phase behavior in magnetic
resonance imaging to determine normal vs. abnormal iron content in
the brain. J Magn Reson Imaging. 26:256–264. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Haddar D, Haacke E, Sehgal V, Delproposto
Z, Salamon G, Seror O and Sellier N: Susceptibility weighted
imaging: Theory and applications. J Radiol. 85:1901–1908. 2004.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Hingwala DR, Kesavadas C, Thomas B and
Kapilamoorthy TR: Susceptibility weighted imaging in the evaluation
of movement disorders. Clin Radiol. 68:e338–e348. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bruehlmeier M, Leenders KL, Vontobel P,
Calonder C, Antonini A and Weindl A: Increased cerebral iron uptake
in Wilson's disease: A 52Fe-citrate PET study. J Nucl Med.
41:781–787. 2000.PubMed/NCBI
|